Validation and maintaining laboratory developed molecular tests compliant with ISO15189 for diagnosis of intestinal

Jaco J Verweij1

  • 1Microvida Laboratory for Medical Microbiology and Immunology, ElisabethTweesteden Hospital, Tilburg, The Netherlands.

Abstract

Insights

This study details setting custom performance standards for validating laboratory-developed tests (LDTs) for intestinal parasitic infections, ensuring ISO 15189 compliance and continuous quality improvement in diagnostics.

Area of Science:

  • Clinical diagnostics
  • Molecular parasitology
  • Laboratory quality management

Background:

  • Molecular diagnostics are established for parasitic infections, but labs hesitate to adopt nucleic acid-based tests due to validation challenges.
  • Implementing laboratory-developed tests (LDTs) requires rigorous validation to meet international standards like ISO 15189.

Purpose of the Study:

  • To provide a framework for setting tailor-made performance characteristics for LDT validation in molecular parasitology.
  • To ensure compliance with ISO 15189 guidelines for diagnostic laboratory tests.
  • To guide the continuous quality improvement of molecular diagnostic testing.

Main Methods:

  • Describing the process of defining and tailoring performance characteristics for LDT validation.
  • Emphasizing the importance of daily monitoring, external quality assessment, and reassessment for test maintenance.
  • Highlighting the flexibility to adapt validation criteria based on specific laboratory needs and evolving insights.

Main Results:

  • A practical approach to validating LDTs for intestinal parasitic infections according to ISO 15189.
  • Demonstration of how tailored validation leads to enhanced quality control and continuous improvement.
  • Establishment of methods for ongoing maintenance and reassessment of molecular diagnostic tests.

Conclusions:

  • Tailored validation of LDTs is crucial for molecular diagnostics of parasitic infections.
  • ISO 15189 compliance can be achieved through customized validation strategies.
  • Continuous quality improvement is facilitated by adaptable performance characteristics and ongoing monitoring.